02830nam 2200649 a 450 991013904610332120200520144314.03-527-67040-83-527-67038-61-299-40220-83-527-67039-4(CKB)2550000001017928(EBL)1157730(OCoLC)833767002(SSID)ssj0000904913(PQKBManifestationID)11494291(PQKBTitleCode)TC0000904913(PQKBWorkID)10941255(PQKB)10801533(MiAaPQ)EBC1157730(MiAaPQ)EBC4044500(Au-PeEL)EBL1157730(CaPaEBR)ebr10677831(CaONFJC)MIL471470(PPN)194570274(EXLCZ)99255000000101792820130403d2013 uy 0engur|n|---|||||txtccrTrypanosomatid diseases[electronic resource] molecular routes to drug discovery /edited by Timo Jäger, Oliver Koch, and Leopold FlohéWeinheim Wiley-VCH20131 online resource (578 p.)Drug discovery in infectious diseases ;v. 4Description based upon print version of record.3-527-33255-3 Includes bibliographical references and index.pt. 1. Disease burden, current treatments, medical needs, and strategic approaches -- pt. 2. Metabolic peculiarities in the trypanosomatid family guiding drug discovery -- pt. 3. Validation and selection of drug targets in kinetoplasts -- pt. 4. Examples of target-based approaches and compounds under consideration.This is the first resource to provide researchers in academia and industry with an urgently needed update summarizing the current knowledge and possibilities for drug intervention against Trypanosomatides all in one volume. As such, it covers every aspect of the topic from basic research findings, via current treatments to translational approaches in drug development and includes both human and livestock diseases. The outstanding editor and contributor team reads like a Who?s Who of the field, thus guaranteeing the outstanding quality of this ready reference.Drug discovery in infectious diseases ;v. 4.Parasitic diseasesTrypanosomatidaeParasitic diseases.Trypanosomatidae.616.936061Jäger Timo964712Koch Oliver964713Flohé Leopold964714MiAaPQMiAaPQMiAaPQBOOK9910139046103321Trypanosomatid diseases2188829UNINA